Introduction:

product name: tranexamic acid

cas:1197-18-8

molecular formula:c8h15no2

molecular weight:157.21

purity: 99%
appearance: white crystalline powder

Applicaton

hemostatic, a significant effect on traumatic bleeding, preoperative prophylactic medication can reduce surgical bleeding.

tranexamic acid for aminomethylbenzoic acid derivatives, is a kind of fibrinolytic hemostatic drug resistance, hemostatic mechanism with the same amino caproic acid, aminomethylbenzoic acid, but the effect is stronger, the intensity of 7 ~ 10 times that of amino caproic acid, aminomethylbenzoic acid 2 times, and similar toxicity. tranexamic acid structure similar to the lysine, can be competitive inhibitory fibrinolytic enzyme on the fibrous protein adsorption, prevent its activation, protect the fibrin degradation by fibrinolytic enzyme and dissolved, ultimately achieve hemostatic effect. limitations are suitable for the treatment of acute or chronic, or systemic primary fibrinolysis hyperfunction caused by all kinds of bleeding, such as the obstetric hemorrhage, renal hemorrhage, prostatic hypertrophy, hemorrhage, hemophilia, tuberculosis, coughing up blood, stomach bleeding, liver, lung, spleen and other visceral bleeding after the operation, etc; when the operation can also be used for abnormal bleeding and so on.

Specification

contact information:                         

Whatsapp:86-18873303856

skype：live:d260a58b346fba38

email：majorina.cai@chembj.com                       

 TEL:+86 18873303856